Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
CMS Proposes Widening MRI Coverage for Cardiac DevicesThe update reflects growing evidence supporting the safety of magnetic resonance imaging of cardiac devices and would extend coverage even to devices without MRI-friendly labeling.
Antibiotics, Antidepressants Dominate New FDA Watch ListPresence on list does not mean a drug has been linked to a risk, only that new safety information is available or potential
risk has been identified and further review will be or has been completed.
Medscape Medical News, January 19, 2018
Doctors Underdiagnosing Flu Among Older PatientsPatients over age 65 who are hospitalized for influenza-like illness were less likely to receive diagnostic tests from providers
than were younger patients, a new study found.
Propranolol May Fill 'Dire' Treatment Need for PTSDPatients with posttraumatic stress disorder (PTSD) who actively recalled their traumatic event under the influence of propranolol
showed a substantial decrease in symptom ratings.
Medscape Medical News, January 19, 2018
More Evidence Links Gum Disease to Stroke RiskA new study shows a relationship between severity of gum disease and increasing future stroke risk, and conversely that regular
dental care was linked to a lower stroke risk.
Medscape Medical News, January 19, 2018
Survival After Breast Cancer 'Unaffected by BRCA Status'The likelihood that young women survive primary breast cancer is unaffected by whether or not they carry mutations in the
BRCA gene, say UK researchers in a 10-year follow-up study.
Burnout Might Really Be Depression; How Do Doctors Cope?Medscape asked physicians whether they experienced burnout, depression, or both. Some experts say that burnout is really a form of depression. Would that change the recommended treatment?
Medscape Business of Medicine, January 17, 2018
Columnists
Piloting Focal Therapy in Prostate CancerFollow-up findings from a phase 1 trial suggest that MR-guided focused ultrasound therapy can be delivered safely in patients with prostate cancer.
Eric J. Topol, MDDirector, Scripps Translational Science Institute; Executive Vice President and Professor of Molecular Medicine, The Scripps Research Institute; Senior Consultant, Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, California; Editor-in-Chief, Medscape
